Leadership & Pay ·
Takeda Pharmaceutical Company Limited announced the issuance of 10,892,917 new shares and the disposal of 6,096,159…
TAKTakeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Company Limited announced the issuance of 10,892,917 new shares and the disposal of 6,096,159 treasury shares, totaling 16,989,076 ordinary shares, under its Long-Term Incentive Plan (LTIP) for employees outside of Japan. The issuance and disposal price is set at 5,050 yen per share, with a total value of 85,794,833,800 yen, scheduled for a payment date of July 8, 2026. Takeda is a biopharmaceutical company that develops and delivers life-transforming treatments in therapeutic areas such as oncology, neuroscience, and vaccines.